Paul Hallenbec [8] have pioneered the efforts in this direction by using α-fetoprotein (AFP) promoters to drive the adenovirus E1A gene to treat hepatocellular carcinoma. This evidence concerns the gene DHTKD1 and hepatocellular carcinoma.